Addex Reports ADX71441 Reduces Alcohol Intake in a Preclinical Model of …
Addex Reports ADX71441 Reduces Alcohol Intake in a Preclinical Model of …
Filed under: drug treatment news 2012
Geneva, Switzerland, 29 October 2012 – (SIX:ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, announced today positive preclinical data for its GABA-B receptor positive allosteric modulator (PAM) oral small …
Read more on Reuters
Israeli medical device offers new Alzheimer's treatment
Filed under: drug treatment news 2012
TEL AVIV | Wed Oct 24, 2012 12:26pm EDT. TEL AVIV (Reuters) – Israel-based Neuronix, which has developed a non-invasive medical device to help to treat Alzheimer's disease, expects the system to be approved by the U.S. Food & Drug Administration in …
Read more on Reuters
Addex Reports ADX71441 Reduces Alcohol Intake In A Preclinical Model Of Alcohol Binge Drinking
Addex Therapeutics / Addex Reports ADX71441 Reduces Alcohol Intake in a Preclinical Model of Alcohol Binge Drinking. Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for … Read News